指南与共识免疫规划传染病防控与疫情报告

亚洲百日咳:近期各国数据与建议

Pertussis in Asia: Recent country-specific data and recommendations.
指南 / 共识 · Vaccine · 2022-01-22

全球百日咳倡议(GPI)2019年圆桌会议聚焦亚洲地区百日咳的发病率、监测和免疫实践,来自中国、印度、印度尼西亚、马来西亚、巴基斯坦、菲律宾、韩国、台湾和泰国的参会者介绍了各国百日咳流行、诊断、监测、疫苗管理和接种程序、孕产妇和新生儿疾病率以及孕期接种政策与实践。近年来许多亚洲国家百日咳病例增加,但存在漏报问题;目前大多数亚洲国家仅实行被动监测,需要改进监测以确定疾病负担并支持疫苗接种政策和建议。

要点

  • 近年来许多亚洲国家百日咳病例增加,但漏报是关注问题。
  • 目前大多数亚洲国家仅实行被动监测。
  • 需要改进监测以确定疾病负担并支持疫苗接种政策和建议。

核心结论

  • 需要改进监测以确定疾病负担并支持疫苗接种政策和建议,如基础免疫、加强免疫和孕期接种。
  • 需要提高青少年和成人对百日咳的认识,许多国家的婴幼儿和儿童接种程序需要改进。
  • 应继续审视私立与公立部门接种程序的差异以及全细胞与无细胞百日咳疫苗的差异。
  • 随着COVID-19大流行演变,百日咳预防和管理方面未满足的需求预计将持续存在,本次会议报告强调的关键建议将持续重要。

研究设计与样本

  • 全球百日咳倡议(GPI)2019年圆桌会议(在COVID-19大流行之前举行),聚焦亚洲地区百日咳的发病率、监测和免疫实践。
  • 来自中国、印度、印度尼西亚、马来西亚、巴基斯坦、菲律宾、韩国、台湾和泰国的参会者介绍了各国百日咳流行、诊断、监测、疫苗管理和接种程序、孕产妇和新生儿疾病率以及孕期接种政策与实践。

主要发现

  • 近年来许多亚洲国家百日咳病例增加,但漏报是关注问题。
  • 目前大多数亚洲国家仅实行被动监测。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The Global Pertussis Initiative (GPI) Roundtable Meeting held in 2019, which preceded the COVID-19 pandemic, focused on the incidence, surveillance, and immunization practices for pertussis in the Asian region. Participants from China, India, Indonesia, Malaysia, Pakistan, Philippines, South Korea, Taiwan, and Thailand presented country-specific information on pertussis prevalence, diagnosis, surveillance, vaccine administration and schedules, maternal and neonatal disease rates, and policies and practice of vaccination during pregnancy. In recent years, many Asian countries have seen an increase in pertussis cases, although underreporting of the disease is a concern. Currently, most Asian countries have only passive surveillance for pertussis in place. There is a need for improved surveillance to determine the disease burden and justify vaccination policies and recommendations, such as essential vaccination, boosters, and vaccination during pregnancy. Better awareness of the disease in adolescents and adults is necessary, and infant and childhood vaccination schedules need to be improved in many countries. Differences between private versus public sector vaccination schedules and between whole-cell and acellular pertussis vaccines should continue to be examined. It can be anticipated that unmet needs in the prevention and management of pertussis will continue as the COVID-19 pandemic evolves and that key recommendations highlighted in this meeting report will be of ongoing importance.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Jog P, Memon IA, Thisyakorn U, et al. Pertussis in Asia: Recent country-specific data and recommendations. Vaccine. 2022. PMID: 35074239. doi:10.1016/j.vaccine.2021.12.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。